Jiangsu Sihuan Bioengineering Co., Ltd. (000518) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Jiangsu Sihuan Bioengineering Co., Ltd.

Why is Jiangsu Sihuan Bioengineering Co., Ltd. ?

Poor Management Efficiency with a low ROCE of 0.40%

The company has been able to generate a Return on Capital Employed (avg) of 0.40% signifying low profitability per unit of total capital (equity and debt)

Poor long term growth as Net Sales has grown by an annual rate of -1.86% and Operating profit at -228.25% over the last 5 years

The company has declared Positive results for the last 4 consecutive quarters

OPERATING CASH FLOW(Y) Highest at CNY 52.57 MM
NET SALES(HY) At CNY 131.18 MM has Grown at 43.58%
NET PROFIT(HY) Higher at CNY -35.69 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 23.81%, its profits have risen by 72.9%

Market Beating performance in long term as well as near term

Along with generating 23.81% returns in the last 1 year, the stock has outperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Jiangsu Sihuan Bioengineering Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Jiangsu Sihuan Bioengineering Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Jiangsu Sihuan Bioengineering Co., Ltd.

23.81%

1.05

45.61%

China Shanghai Composite

16.78%

1.20

13.96%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-1.86%

EBIT Growth (5y)

-228.25%

EBIT to Interest (avg)

-20.68

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.01

Sales to Capital Employed (avg)

0.66

Tax Ratio

0.71%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

0.40%

ROE (avg)

0.14%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

10.29

EV to EBIT

-77.46

EV to EBITDA

-105.12

EV to Capital Employed

11.98

EV to Sales

8.58

PEG Ratio

Dividend Yield

ROCE (Latest)

-15.47%

ROE (Latest)

-10.73%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

20What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 52.57 MM

NET SALES(HY)

At CNY 131.18 MM has Grown at 43.58%

NET PROFIT(HY)

Higher at CNY -35.69 MM

CASH AND EQV(HY)

Highest at CNY 164.81 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 1.02 times

DEBTORS TURNOVER RATIO(HY)

Highest at 5.24 times

-1What is not working for the Company

RAW MATERIAL COST(Y)

Grown by 70.3% (YoY

Here's what is working for Jiangsu Sihuan Bioengineering Co., Ltd.

Net Sales

At CNY 131.18 MM has Grown at 43.58%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very positive

Net Sales (CNY MM)

Operating Cash Flow

Highest at CNY 52.57 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Profit

Higher at CNY -35.69 MM

than preceding 12 month period ended Mar 2026

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (CNY MM)

Net Profit

At CNY -35.69 MM has Grown at 67.94%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Cash and Eqv

Highest at CNY 164.81 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Inventory Turnover Ratio

Highest at 1.02 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio

Highest at 5.24 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Jiangsu Sihuan Bioengineering Co., Ltd.

Raw Material Cost

Grown by 70.3% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales